Trials / Conditions / Contact Dermatitis

Contact Dermatitis

25 registered clinical trials studyying Contact Dermatitis — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Active Not Recruiting	Methotrexat to Hand Eczema in the BIOSKIN Cohort NCT07338305	Lone Skov	—
Recruiting	Novel Skin Barrier Product Versus Petrolatum for Skin Barrier Dysfunction NCT07183423	Makati Medical Center	N/A
Completed	A Clinical Evaluation of Marula-Derived Ceramide Cream on Skin Barrier Function Enhancement NCT07066150	Shanghai Chicmax Cosmetic Co., Ltd.	N/A
Completed	DermAI to Evaluate Human Factor of Testing NCT06387472	Mayo Clinic	N/A
Unknown	Assessment of Niacinamide Cosmetic Product Efficacy in Model of Irritant Contact Dermatitis NCT06331390	University of Split, School of Medicine	N/A
Unknown	Testing an Intervention in Irritative Contact Dermatitis NCT06189144	University of Split, School of Medicine	N/A
Unknown	Molecular Diagnosis of Allergic Contact Dermatitis NCT06177314	Hospices Civils de Lyon	—
Unknown	A Safety, Tolerability, and Dermal Reactogenicity Study of PDC-APB NCT04853823	Hapten Sciences, Inc.	Phase 1
Completed	Children With Aluminium Contact Allergy: Oral Exposure Study NCT04921163	National Allergy Research Center, Denmark	N/A
Completed	Study on Hypoallergenic Hair Dye NCT04772482	University of Minnesota	—
Completed	Children With Aluminium Contact Allergy: Cutaneous Exposure Study NCT04438135	National Allergy Research Center, Denmark	N/A
Unknown	Prevention of Dermatitis in Epoxy Exposed Workers NCT03705182	Aarhus University Hospital	N/A
Terminated	Linking Epidermal Barrier Function With Anti-Oxidant Defense Mechanisms in Skin Conditions NCT03198390	University of Arizona	—
Completed	Evaluation of Safety and Efficacy of BBI-2000 in Treating and Preventing Contact Dermatitis NCT03089775	Fresh Tracks Therapeutics, Inc.	Phase 1
Completed	A Phase I, Single-Center Study of PDC-APB in Healthy Volunteers NCT02700373	Hapten Sciences, Inc.	Phase 1
Unknown	Bariederm Cream in Chronic Contact Dermatitis NCT02026700	Hadassah Medical Organization	N/A
Completed	Clinical Evaluation of Metal Panel Allergens: Mercury, Aluminum and Palladium Dose Response Study NCT02028208	Allerderm	Phase 2
Completed	Clinical Evaluation of Lyral® Dose Response Study NCT02028182	Allerderm	Phase 2
Withdrawn	Clinical Evaluation of T.R.U.E. TEST Panel 3.2 in Children and Adolescents NCT01518348	Allerderm	Phase 3
Completed	Exploratory Study of Natural Killer Cells in Human Skin NCT00824889	Assistance Publique Hopitaux De Marseille	N/A
Completed	Clinical Evaluation of T.R.U.E. TEST® : Safety and Efficacy NCT00640614	Allerderm	Phase 3
Completed	Clinical Evaluation of T.R.U.E. TEST® Panel 3.2 Allergens: Dose Response NCT00640250	Allerderm	Phase 2
Completed	Effect of Tetrix on Alleviation of Burning,Itching Associated With Lesions of Contact Dermatitis NCT00646867	Coria Laboratories, Ltd.	N/A
Completed	Molecular and Cellular Characterization of Spongiotic Dermatitis NCT00371163	University of California, Davis	—
Completed	Novel Topical Treatment of Hand Dermatitis (Eczema) NCT00614289	Biomedical Development Corporation	Phase 1